The rapid advancements in gene editing and vaccine development, particularly highlighted by the Covid pandemic, signal a transformative era in healthcare. With technologies like CRISPR and messenger RNA, there is potential to tackle diseases more effectively and extend human lifespan. This shift not only impacts individual health but also poses significant implications for industries like insurance and pensions, as longer life expectancy may reshape workforce dynamics and labor markets.
